Risk of Coronavirus Disease 2019–Associated Pulmonary Aspergillosis Based on Corticosteroid Duration in Intensive Care Patients

BACKGROUND: Coronavirus disease 2019 (COVID-19)–associated pulmonary aspergillosis (CAPA) is a potential complication in critically ill COVID-19 patients. Corticosteroids are standard of care for hospitalized COVID-19 patients but carry an increased risk of secondary infections including CAPA. The o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Meera, Reveles, Kelly, Moote, Rebecca, Hand, Elizabeth, Kellogg III, Dean, Attridge, Rebecca L, Maselli, Diego J, Gutierrez, G Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984984/
https://www.ncbi.nlm.nih.gov/pubmed/36879627
http://dx.doi.org/10.1093/ofid/ofad062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984984/
https://www.ncbi.nlm.nih.gov/pubmed/36879627
http://dx.doi.org/10.1093/ofid/ofad062

Ejemplares similares